Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 13.9611.0922.7930.42-2.27

What is the latest EV/Core EBITDA ratio of BAFNA PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of BAFNA PHARMACEUTICALS is 13.96 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar202413.96
Mar202311.09
Mar202222.79
Mar202130.42
Mar2020-2.27

How is EV/Core EBITDA of BAFNA PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 13.96
25.88
Mar2023 11.09
-51.34
Mar2022 22.79
-25.08
Mar2021 30.42
Positive
Mar2020 -2.27 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹212.1 Cr 0.9% 20.6% 6.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,712.0 Cr -1.3% 1% 7.9% Stock Analytics
DIVIS LABORATORIES ₹176,623.0 Cr -3.2% -0.3% 48% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,285.0 Cr 1.2% 10.7% 19.5% Stock Analytics
CIPLA ₹119,010.0 Cr -0.6% -2.2% -0.7% Stock Analytics
DR REDDYS LABORATORIES ₹104,118.0 Cr -1.5% -5.9% -5.1% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

0.9%

20.6%

6.1%

SENSEX

-0.5%

-0.3%

1%


You may also like the below Video Courses